DOES JCV ANTIBODY POSITIVITY ENCOURAGE CESSATION OF NATALIZUMAB THERAPY IN MULTIPLE SCLEROSIS?
Roisin Lonergan, Katie Kinsella, Siobhan Kelly, Marguerite Duggan, Jacqueline Scott, Killian O'Rourke, Timothy Lynch, Michael Hutchinson, Niall Tubridy, Christopher McGuigan
Journal of Neurology, Neurosurgery & Psychiatry Nov 2013, 84 (11) e2; DOI: 10.1136/jnnp-2013-306573.181